The Jett Foundation Fighting Duchenne Muscular Dystrophy

FDA Approval of eteplirsen, September 19, 2016. This is the first therapy for the treatment of Duchenne granted Accelerated Approval by the FDA.   Click here to learn more.

Thanks to everyone who made our Cooking for a Cause event a huge hit! Your support helps us further research efforts, educate and advocate for our community, and run programs for boys with Duchenne. To donate today, click here.

Save the date! Join us for our annual Golf Classic fundraiser on Wednesday, June 1, 2016. For more information, click here.

Looking for a team to join or a race to put your New Year’s resolution into action? Join one of our triathlon teams and get ready for 2016! For more information about joining our Tri for Jett or Gals For Cal, click here.

Are you looking for an accessible summer camp option for your child? Camp Promise is our FREE overnight camp for people of all ages with muscular dystrophy and select neuromuscular diseases. For more information, click here.

Buy your tickets today – All proceeds will go towards helping our Duchenne community.

Our Mission

The mission of the Jett Foundation is to increase worldwide awareness of Duchenne muscular dystrophy with the purpose of raising and appropriating funds for research that will realize a cure for this fatal disease and programming that will ensure children with Duchenne have the opportunity to enjoy a full life.


Please check us out! Donations Appreciated

Screen Shot 2016-09-06 at 2.47.54 PM


Facebook Feed

The Jett Foundation
The Jett FoundationSaturday, October 1st, 2016 at 4:53am
#JettFoundation Industry Partner Santhera Pharmaceuticals starts Phase 3 Raxone study in #DMD patients on steroids
The Jett Foundation
The Jett FoundationFriday, September 30th, 2016 at 5:06am
#tyt Thank You Thursday to companies like Yale Appliance + Lighting for supporting #JettFoundation through the years! #DuchenneDrugApproval #DuchenneCommunity


Twitter Feed

Saturday, October 1st, 2016 at 1:53am
#JettFoundation Industry Partner Santhera Pharmaceuticals starts Phase 3 Raxone study in #DMD patients on steroids


Stay in Touch

If you’d like to receive emails from the Jett Foundation, please sign up for our email newsletter.

Upcoming Events

Komedy for A Kause – Tickets on Sale now!

  Who doesn’t need a good laugh?  Please join us for some good fun for a great cause! Who: Lenny Clarke along with 6 other hilarious comedians When:  Friday October 14, 2016 7pm Where:  Plymouth Memorial Hall, 83 Court Street, Plymouth, MA All Proceeds will benefit the Jett Foundation and our new First Giving JettAbility […]


Jett Foundation/FDA Approval news

September 28, 2016

On September 19, 2016, the FDA granted accelerated approval for eteplirsen, making it the first approved therapy for Duchenne muscular dystrophy.  This historic approval has been the focus of many news items, below are some news coverage that highlights Jett Foundation’s advocacy efforts and impact. Published September 24, 2016 For one mother bittersweet victory, long […]

Show Buttons
Hide Buttons